Minoxidil and Zaleplon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Minoxidil and Zaleplon. Common interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people who take Minoxidil and Zaleplon have. It is created by eHealthMe based on reports of 8 people who take Minoxidil and Zaleplon from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 31, 2023

8 people who take Minoxidil and Zaleplon together, and have interactions are studied.


What is Minoxidil?

Minoxidil has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 18,362 Minoxidil users for its effectiveness, alternative drugs and more.

What is Zaleplon?

Zaleplon has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 1,691 Zaleplon users for its effectiveness, alternative drugs and more.

Number of Minoxidil and Zaleplon reports submitted per year:

Minoxidil and Zaleplon drug interactions.

Common Minoxidil and Zaleplon drug interactions by gender *:

female:

  1. Drug ineffective
  2. Weight increased
  3. Stress
  4. Suicidal ideation
  5. Drug hypersensitivity
  6. Basedow's disease
  7. Brain stem stroke
  8. Convulsions
  9. Diabetes mellitus
  10. Drug effect decreased

male:

n/a

Common Minoxidil and Zaleplon drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Convulsions
  2. Drug effect decreased

30-39:

  1. Basedow's disease
  2. Brain stem stroke
  3. Diabetes mellitus
  4. Enuresis
  5. Suicidal ideation

40-49:

n/a

50-59:

n/a

60+:

  1. Drug ineffective
  2. Weight increased
  3. Drug hypersensitivity
  4. Malaise
  5. Stress

* Approximation only. Some reports may have incomplete information.

Do you take Minoxidil and Zaleplon?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Minoxidil and Zaleplon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Minoxidil side effects:

Browse all side effects of Minoxidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zaleplon side effects:

Browse all side effects of Zaleplon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Minoxidil interactions:

Browse all interactions between Minoxidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zaleplon interactions:

Browse all interactions between Zaleplon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on minoxidil and zaleplon (the active ingredients of Minoxidil and Zaleplon, respectively), and Minoxidil and Zaleplon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Minoxidil and Zaleplon.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: